Tuesday - April 07, 2026

Category Archives: Pharmaceuticals & Biotech

Bullous Pemphigoid Market Forecast 2034: Explore Next-Gen Treatments, Regulatory Milestones, and Competitive Intelligence | DelveInsight

Bullous Pemphigoid Market Bullous Pemphigoid Companies working in the treatment market are AstraZeneca, Kyowa Kirin, Regeneron,Sanofi, Argenx, Innate Pharma, ARTham Therapeutics, Kaken Pharmaceutical, Mayo Clinic, Nihon Pharmaceutical Co., Ltd, Immune Pharmaceuticals, AKARI Therapeutics and others. DelveInsight’s “Bullous Pemphigoid Market Insights, … Continue reading →

Chronic Hand Eczema Market Forecast 2034: Explore Next-Gen Treatments, Regulatory Milestones, and Competitive Intelligence | DelveInsight

Chronic Hand Eczema Market Key players in the Chronic Hand Eczema market include Basilea Pharmaceutica, Stiefel Laboratories, LEO Pharma, Asana Biosciences, and Incyte Corporation, among others. DelveInsight’s report, “Chronic Hand Eczema Market Insights, Epidemiology, and Market Forecast – 2034,” delivers … Continue reading →

Common Warts Treatment Market Outlook 2034: Insights on Clinical Trials, FDA/EMA/PMDA Approvals, NDA Progress, Therapeutics, Disease Prevalence, Mechanisms, Market Size, Key Companies | DelveInsight

Common Warts Treatment Market Key companies actively involved in the Common Warts market include KinoPharma Inc., Veradermics, Inc., Labo’Life, Merck Sharp & Dohme LLC, Shanghai Zerun Biotechnology, X4 Pharmaceuticals, Nielsen BioSciences, Verrica Pharmaceuticals, Aclaris Therapeutics, Inc., ViroXis Corporation, Maruho Co., … Continue reading →

Alopecia Treatment Market Outlook 2032: Discover High-Growth Opportunities, Emerging Therapies, and Key Company Strategies | DelveInsight

Alopecia Treatment Market Alopecia companies are Aclaris Therapeutics Inc., Concert Pharmaceuticals Inc., Daiichi Sankyo Inc., HCell Inc., Merck & Co. Inc., Sun Pharmaceuticals Industries Ltd, Cipla, Dr. Reddy’s Laboratories Ltd, Viviscal, Histogen, Follica Inc., Kythera Biopharmaceuticals Inc., Regaine, Ranbaxy Laboratories … Continue reading →

Cytomegalovirus Infection Clinical Trial Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Cytomegalovirus (CMV) Infection Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in the Cytomegalovirus Infection pipeline landscape. It covers the Cytomegalovirus Infection pipeline drug profiles, including clinical and nonclinical stage products. It also … Continue reading →

Clostridium Difficile Infections Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Clostridium Difficile Infections Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Clostridium Difficile Infections pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Human Papillomavirus-positive Oropharyngeal Cancer Clinical Trial Pipeline Expands as 5+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Human Papillomavirus-positive Oropharyngeal Cancer Pipeline Insight 2026” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Human Papillomavirus-positive Oropharyngeal Cancer pipeline landscape. It covers the Human Papillomavirus-positive Oropharyngeal Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading →

Influenza Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Influenza Pipeline Insight 2026” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in the Influenza pipeline landscape. It covers the Influenza Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Influenza Pipeline … Continue reading →